| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.03▲ | 2.03▲ | 2.04▼ | 2.12▼ | 2.12▼ |
| MA10 | 2.03▲ | 2.04▼ | 2.02▲ | 2.17▼ | 1.78▲ |
| MA20 | 2.04▼ | 2.04▼ | 2.08▼ | 2.14▼ | 1.58▲ |
| MA50 | 2.05▼ | 2.14▼ | 2.18▼ | 1.73▲ | 1.46▲ |
| MA100 | 2.13▼ | 2.19▼ | 2.13▼ | 1.54▲ | 2.30▼ |
| MA200 | 2.19▼ | 2.15▼ | 2.02▲ | 1.37▲ | 3.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.007▲ | 0.001▲ | -0.040▼ | 0.096▲ |
| RSI | 49.597▼ | 43.858▼ | 41.019▼ | 51.122▲ | 61.090▲ |
| STOCH | 50.000 | 67.268 | 59.748 | 44.239 | 76.838 |
| WILL %R | -50.000 | -24.000▲ | -60.417 | -70.492 | -33.861 |
| CCI | 45.487 | 24.645 | -26.534 | -69.973 | 80.284 |
|
Wednesday, November 05, 2025 01:19 PM
About Acumen Pharmaceuticals, Inc. Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the ...
|
|
Tuesday, November 04, 2025 01:09 PM
The live webcasts may be accessed under the Investors tab on www.acumenpharm.com and will be archived for 90 days.
|
|
Wednesday, October 01, 2025 04:03 AM
) has been revised to $8.67 / share. This is an increase of 11.84% from the prior estimate of $7.75 dated September 10, 2025. The price target is an average of many targets provided by analysts. The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/25 | 1.95 | 2.085 | 1.95 | 2.03 | 85,900 |
| 04/11/25 | 2.14 | 2.16 | 1.94 | 1.94 | 275,400 |
| 03/11/25 | 2.21 | 2.24 | 2.11 | 2.18 | 198,200 |
| 31/10/25 | 2.22 | 2.30 | 2.147 | 2.21 | 239,000 |
| 30/10/25 | 2.27 | 2.33 | 2.19 | 2.22 | 117,100 |
| 29/10/25 | 2.305 | 2.37 | 2.22 | 2.26 | 210,700 |
| 28/10/25 | 2.21 | 2.46 | 2.12 | 2.29 | 704,183 |
| 27/10/25 | 2.24 | 2.24 | 2.12 | 2.20 | 270,500 |
| 24/10/25 | 2.12 | 2.35 | 2.1103 | 2.21 | 472,960 |
| 23/10/25 | 1.90 | 2.15 | 1.90 | 2.11 | 442,400 |
|
|
||||
|
|
||||
|
|